You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ACRS Exercise Disclosure
Gowen Maxine · SEC Form 4 · Filed Jun 8, 2026
Exercise
Calculated transaction value
$0
Gowen Maxine Director
ACRS
Aclaris Therapeutics
ACRS
Transaction date
Jun 5, 2026
Public filing date
Jun 8, 2026
Filing lag
Filed 3 days later
ACRS daily price context
Close on/before transaction
$4.36
Jun 5, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 11,580 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001280044-26-000004
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aclaris Therapeutics, Inc. ACRS | Exercise | Jun 5, 2026 | Not reported |
| Aclaris Therapeutics, Inc. ACRS Current | Exercise | Jun 5, 2026 | $0 |
| Aclaris Therapeutics, Inc. ACRS | Award | Jun 4, 2026 | $0 |
| Aclaris Therapeutics, Inc. ACRS | Award | Jun 4, 2026 | $0 |